Bleeding Patterns of Infants and Toddlers With von Willebrand Disease
Researchers sought to define bleeding patterns and other characteristics in infants and toddlers with von Willebrand disease.
Diagnosis & Disease Information
Recombinant von Willebrand Factor Prophylaxis Effective at Preventing Bleeding in Patients With von Willebrand Disease
Researchers sought to determine whether recombinant VWF would be effective in reducing spontaneous bleeding for patients with severe VWD previously treated in an on-demand manner.
Updates on the Etiology, Diagnosis, Management of von Willebrand Syndrome and Hemophilia A
Acquired hemophilia A (AHA) and acquired von Willebrand syndrome (aVWS) are rare, life-threatening bleeding disorders that occur in patients with no bleeding history and no family history of a bleeding disorder.
First-in-Human Results Show Promise With BT200, a New Anti-von Willebrand Factor Agent
Researchers sought to determine whether BT200, a new anti-von Willebrand factor, would have efficacy in patients with von Willebrand disease.
Characteristics of Infants, Toddlers With von Willebrand Disease
Researchers sought to determine the characteristics and diagnosis of infants and toddlers diagnosed with von Willebrand disease.
Recombinant von Willebrand Factor Is an Effective Treatment for Patients With von Willebrand Disease
Researchers performed an analysis to determine whether recombinant VWF given with surgery would be safe and effective in preventing bleeding in patients with VWD.
von Willebrand Factor Antigen to ADAMTS13 Ratio May Cause Immunothrombosis in COVID-19
Does the von Willebrand factor antigen/ADAMTS13 ratio contribute to immunothrombosis and predict mortality in patients with COVID-19?
Bleeding Disorders: What Your Patients Need to Know
Whether inherited or acquired, bleeding disorders can cause significant pain, inconvenience, and stress in a person’s life. When patients think they or a loved one may have a bleeding disorder, what should they know?
Highlights of the 2021 Joint Guidelines for Managing von Willebrand Disease
These guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and healthcare professionals in their decisions affecting the management of VWD.
von Willebrand Factor Plasma Levels May Affect Future Venous Thromboembolism Risk
A population-based analysis suggested that plasma levels of von Willebrand factor may be a potential biomarker for the future risk of incident venous thromboembolism.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...